HEIFX
Price
$14.17
Change
-$0.13 (-0.91%)
Updated
Mar 10 closing price
Net Assets
55.16M
RLBCX
Price
$33.88
Change
-$0.55 (-1.60%)
Updated
Mar 10 closing price
Net Assets
237.28B
Ad is loading...

HEIFX vs RLBCX

Header iconHEIFX vs RLBCX Comparison
Open Charts HEIFX vs RLBCXBanner chart's image
Hennessy Equity and Income Investor
Price$14.17
Change-$0.13 (-0.91%)
VolumeN/A
Net Assets55.16M
American Funds American Balanced R3
Price$33.88
Change-$0.55 (-1.60%)
VolumeN/A
Net Assets237.28B
HEIFX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HEIFX vs. RLBCX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEIFX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 237B vs. HEIFX (55.2M). RLBCX pays higher dividends than HEIFX: RLBCX (1.65) vs HEIFX (0.50). HEIFX was incepted earlier than RLBCX: HEIFX (23 years) vs RLBCX (23 years). HEIFX (1.58) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 171.00 vs. HEIFX (16.00). RLBCX has a lower initial minimum investment than HEIFX: RLBCX (250) vs HEIFX (2500). RLBCX annual gain was more profitable for investors over the last year : 4.82 vs. HEIFX (-1.11). RLBCX return over 5 years is better than : 32.76 vs. HEIFX (2.60).
HEIFXRLBCXHEIFX / RLBCX
Total Expense Ratio1.580.89178%
Annual Report Gross Expense Ratio1.580.89178%
Fund Existence23 years23 years-
Gain YTD2.9520.938315%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets55.2M237B0%
Annual Yield % from dividends0.501.6530%
Returns for 1 year-1.114.82-23%
Returns for 3 years-4.5316.52-27%
Returns for 5 years2.6032.768%
Returns for 10 years-7.8850.74-16%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTO3.170.22
+7.46%
Aptose Biosciences. Inc.
CRL175.926.65
+3.93%
Charles River Laboratories International
CFB15.99N/A
N/A
CrossFirst Bankshares
XENE36.50-0.78
-2.09%
Xenon Pharmaceuticals
ALEC1.44-0.14
-8.86%
Alector